Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Clinical trial NCT04926818 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04926818
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2026-03-25
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.